A research initiative, valued at £1 million and situated in Shropshire, aims to decrease the duration patients wait for a bowel cancer diagnosis. This year-long investigation is scheduled to be conducted at the Community Diagnostic Centre (CDC) in Telford, involving approximately 6,000 symptomatic individuals referred by the Shrewsbury and Telford Hospital NHS Trust (SaTH). The study will pilot an innovative test employing a device to gather rectal mucus samples, which are subsequently analyzed in a laboratory to detect abnormal cells. This diagnostic method seeks to substantially lessen the necessity for an invasive colonoscopy, a procedure that typically takes around 45 minutes, necessitates comprehensive bowel preparation, and an additional hospital visit. Should the technology prove effective, 8 out of 10 patients could ascertain whether they are cancer-free within five days of undergoing the test, according to SaTH. The Trust further indicated that the study is also expected to alleviate strain on staff operating beyond their capacity and generate cost savings for the organization. Post navigation Inquiry Commences into Woman’s Death on Psychiatric Ward Mothers Credit Mental Health Service with Preserving Families